These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 662862)

  • 21. Studies on the mechanism of the dopamine-mediated inhibition of prolactin secretion.
    MacLeod RM; Lehmeyer JE
    Endocrinology; 1974 Apr; 94(4):1077-85. PubMed ID: 4818768
    [No Abstract]   [Full Text] [Related]  

  • 22. DNA synthesis and depletion of prolactin in the pituitary gland of the male rat.
    Lloyd HM; Jacobi JM; Meares JD
    J Endocrinol; 1978 Apr; 77(1):129-36. PubMed ID: 641429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of reserpine on the inhibition of prolactin released from different pituitary constructs in vitro by dopamine, bromocriptine and apomorphine.
    Dutt A; Juneja HS
    Endocr Res; 1992; 18(4):307-20. PubMed ID: 1473523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of prolactin-secreting effect produced by repeated administration of haloperidol in the avoidance situation and dopamine neurons in rats.
    Hayashi T; Kifune A; Tadokoro S
    Jpn J Pharmacol; 1988 Nov; 48(3):387-90. PubMed ID: 3221537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of THIP and SL 76002, two clinically experimented GABA-mimetic compounds, on anterior pituitary GABA receptors and prolactin secretion in the rat.
    Apud JA; Masotto C; Racagni G
    Life Sci; 1987 Mar; 40(9):871-81. PubMed ID: 3029529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Octopamine and phenylethylamine inhibit prolactin secretion both in vivo and in vitro.
    Becú-Villalobos D; Thyssen SM; Rey EB; Lux-Lantos V; Libertun C
    Proc Soc Exp Biol Med; 1992 Feb; 199(2):230-5. PubMed ID: 1741415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of haloperidol on the synthesis of DNA in the pituitary gland of the rat.
    Machiavelli GA; Jahn GA; Kalbermann LE; Szijan I; Alonso GE; Burdman JA
    Horm Metab Res; 1982 Mar; 14(3):150-3. PubMed ID: 7068107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of chronic haloperidol to affect prolactin secretion due to acute haloperidol administration.
    Parati EA; Parenti M; Locatelli V; Penalva A; Tamminga C; Müller EE
    Pharmacol Res Commun; 1985 May; 17(5):407-15. PubMed ID: 4034625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the effects of the mammary carcinogen 7,12-dimethylbenz(a)anthracene on release and synthesis of prolactin by rat pituitaries in vitro.
    Ingleton PM
    Eur J Cancer (1965); 1977 Sep; 13(9):1041-8. PubMed ID: 410645
    [No Abstract]   [Full Text] [Related]  

  • 30. Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro.
    Giacomelli S; Palmery M; Romanelli L; Cheng CY; Silvestrini B
    Life Sci; 1998; 63(3):215-22. PubMed ID: 9698051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolactin release inhibiting and stimulating factors in the hypothalamus.
    Arimura A; Schally AV
    Adv Exp Med Biol; 1977; 87():237-52. PubMed ID: 19952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cadmium exposure disrupts GABA and taurine regulation of prolactin secretion in adult male rats.
    Caride A; Fernández-Pérez B; Cabaleiro T; Esquifino AI; Lafuente A
    Toxicol Lett; 2009 Mar; 185(3):175-9. PubMed ID: 19382341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of drugs infused into a rat hypophysial portal vessel on prolactin and growth hormone release.
    Abe H; Kato Y; Chihara K; Iwasaki Y; Imura H
    Proc Soc Exp Biol Med; 1980 Nov; 165(2):248-52. PubMed ID: 6160593
    [No Abstract]   [Full Text] [Related]  

  • 34. Endogenous opiates block dopamine inhibition of prolactin secretion in vitro.
    Enjalbert A; Ruberg M; Arancibia S; Priam M; Kordon C
    Nature; 1979 Aug; 280(5723):595-7. PubMed ID: 223069
    [No Abstract]   [Full Text] [Related]  

  • 35. Paradoxical effect of neuroleptic drugs on prolactin secretion by rat pituitary cell cultures.
    Braghiroli L; Ponzianelli A; Mazzanti G
    Life Sci; 1999; 65(14):1455-61. PubMed ID: 10530797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation of gamma-amino butyric acid from pig hypothalami and demonstration of its prolactin release-inhibiting (PIF) activity in vivo and in vitro.
    Schally AV; Redding TW; Arimura A; Dupont A; Linthicum GL
    Endocrinology; 1977 Mar; 100(3):681-91. PubMed ID: 401021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-Hydroxyoestradiol acutely inhibits prolactin secretion from the superfused pituitary glands of normal female rats: evidence for a cyclical effect.
    Banks PK; Inkster SE; White N; Jeffcoate SL
    J Endocrinol; 1986 Nov; 111(2):199-204. PubMed ID: 3794579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rotational behavior induced in rats by intranigral application of GABA-related drugs and GABA antagonists.
    Olpe HR; Schellenberg H; Koella WP
    Eur J Pharmacol; 1977 Oct; 45(3):291-4. PubMed ID: 562761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GABA-mediated control of rat neostriatal tyrosine hydroxylase revealed by intranigral muscimol.
    Gale KN; Guidotti A
    Nature; 1976 Oct; 263(5579):691-3. PubMed ID: 10528
    [No Abstract]   [Full Text] [Related]  

  • 40. Changes in mediobasal hypothalamic dopamine and GABA release: a possible mechanism underlying taurine-induced prolactin secretion.
    Arias P; Jarry H; Convertini V; Ginzburg M; Wuttke W; Moguilevsky J
    Amino Acids; 1998; 15(1-2):5-11. PubMed ID: 9871483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.